C

Astrana Health, Inc. ASTH

$38.65 $1.925.21% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$35.65$38.87
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

ASTH Rating

Reward
Risk

ASTH Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ASTH Company Overview

Astrana Health, Inc. is a U.S.-based healthcare management and value-based care company focused on coordinating and delivering medical services through physician-centric care models. The company operates primarily in the healthcare services and managed care industries, with a focus on value-based reimbursement arrangements that emphasize population health management, preventive care, and cost efficiency. Astrana Health works with physicians, health plans, hospitals, and healthcare systems to manage care for patients across Medicare, Medicaid, commercial insurance, and ACA marketplace programs. Its business model centers on aligning provider incentives with patient outcomes through risk-sharing and coordinated care programs.

The company’s primary revenue drivers include capitation payments, risk pool settlements, healthcare management services, care coordination, and clinical operations through affiliated physician groups and management entities. Astrana Health evolved from Apollo Medical Holdings, Inc., which merged with Network Medical Management, Inc. in 2017 to expand its integrated care management capabilities. In 2024, the company formally rebranded as Astrana Health to reflect its broader healthcare platform strategy and national growth ambitions. The company has positioned itself as a technology-enabled physician enablement platform with a significant focus on underserved and multicultural patient populations, particularly within Medicare Advantage and government-sponsored healthcare programs.

Data compiled by narrative technology. May contain errors.
Sector

ASTH Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ASTH Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ASTH Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ASTH Price History

Loading...
52-Week Range61% of range
Current
$38.65
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ASTH Valuation

Market Cap
Market Cap Rank
#5,646
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ASTH Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

ASTH Corporate Info

Phone Number
626 282 0288
Address
1668 S. Garfield Avenue
2nd Floor
Alhambra, CA 91801
Country
Year Founded

ASTH Filings

Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

ASTH Headlines